Computationally guided design of N4-(2-methyl-2H-indazol-6-yl)-N2-phenylpyrimidine-2,4-diamine inhibitors of EGFR kinase targeting Cys797

Simple item page
dc.contributor.authorAdchata Konsue
dc.contributor.authorDuangkamol Gleeson
dc.contributor.authorKiattawee Choowongkomon
dc.contributor.authorDonald J.L. Jones
dc.contributor.authorPimkhuan Hannanta-anan
dc.contributor.authorRobert G. Britton
dc.contributor.authorM. Paul Gleeson
dc.date.accessioned2026-05-08T19:25:58Z
dc.date.issued2026-1-2
dc.identifier.doi10.1016/j.bmc.2025.118544
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/20375
dc.publisherBioorganic & Medicinal Chemistry
dc.subjectLung Cancer Treatments and Mutations
dc.subjectFibroblast Growth Factor Research
dc.subjectHER2/EGFR in Cancer Research
dc.titleComputationally guided design of N4-(2-methyl-2H-indazol-6-yl)-N2-phenylpyrimidine-2,4-diamine inhibitors of EGFR kinase targeting Cys797
dc.typeArticle

Files

Collections

All